Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 378 of 673

Advanced search

🇺🇸Jul 31Researchrarediseases.orgTier 2 · Direct publisher

NORD Calls for Substantive Changes to Medicaid Work Requirement Rule

NORD Rare DiseasesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Facing FDA Decision In August 2026

RTTNewsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Renaissance Wages War on Wireworms in New Challenge for Targeted Biotech

techcouver.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech (MBRX) Reports Preliminary Phase 2/3 Trial Dat

GuruFocusOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Maharashtra Food Safety Crackdown Faces Legal Backlash and Industry Opposition

AD HOC NEWSOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod

Fierce PharmaOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Pfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings

Indian Pharma PostOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail

fiercebiotech.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Is Maharashtra FDA Suspending Licences Without Issuing Notices? Tukaram Mundhe Responds

NDTV ProfitOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk ziltivekimab heart drug fails phase 3 trial

qz.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk ziltivekimab heart drug fails phase 3 trial

Yahoo FinanceOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules

biospace.comOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Novo Nordisk inflammation-targeting drug misses mark in heart disease study

STATOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Kaigene maps final territory for KG006 with Taisho deal, embedding Japan partner in global Phase III trial

allsci.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk Plunges 10 Percent After Cardiovascular Drug Fails Trial

streamlinefeed.co.keOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

CDSCO Flags 159 Substandard Drug Samples As NSQ, Including 14 Linked To Maharashtra

Free Press JournalOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Legend CEO departs without successor in place—Chutes & Ladders

Fierce BiotechOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk Shakes Markets as Ziltivekimab Fails Cardiovascular Trial

streamlinefeed.co.keOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

‘We Are in India, We Have To Take a Realistic Stand’: Bombay High Court Quashes FDA Action Against Park

latestly.comOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech

Fierce BiotechOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules

FinancialContentOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Spartanburg pharmaceutical facility to close, layoff nearly 200 employees

FOX Carolina NewsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

AbbVie (NYSE: ABBV) boosts Q2 profit, plans $10.9B Apogee acquisition

Stock TitanOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

AbbVie Reports Second-Quarter 2026 Financial Results

TradingViewOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

FDA says Mantralaya canteen 98% clean, Bombay High Court orders lawyers' inspection

India TodayOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Biogen is scaling back acquisitions and will focus on its existing pipeline

medwatch.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics reports Q2 net loss $17.8M, cash $118.0M; LEVEL Phase 3 topline due Aug 2026

TradingViewOriginal source

🇯🇵Jul 31Industrynippon-shinyaku.co.jpTier 1 · Company source

日本新薬レポート2026 発刊のお知らせ

Nippon Shinyaku NewsOriginal source

🇺🇰Jul 31Regulatorygov.ukTier 1 · Regulatory source

2024 VPAG operational review minutes

Minutes of meetings held between the government, NHS England and ABPI about the 2024 voluntary schem...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 31Regulatorygov.ukTier 1 · Regulatory source

2024 VPAG operational review: 12 August 2025

Minutes of a meeting held between the government, NHS England and ABPI about the 2024 voluntary sche...

UK Department of Health and Social CareOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Warsaw’s world-first liver transplant puts EU biotech rules in the spotlight

euractiv.comOriginal source

🌍Jul 31Industrysinopharmtech.comTier 1 · Company source

SinoPharmtech and Chinese partners at a meeting at the National Academy of Sciences of the Republic of Belarus

Sinopharm TechOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

manilatimes.netOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Ziltivekimab lowered inflammation markers, not major heart events

Stock TitanOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Vogenx targets modest Nasdaq IPO to back metabolic drug

The Pharma LetterOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Advertising Laws and Regulations 2026

Arthur Cox LLPOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Mumbai's Girgaon Chowpatty Vendors Wear FSSAI Aprons As FDA Tightens Food Safety Drive

lokmattimes.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical Co. (OPHLF) Q1 Earnings and Revenues Top Estimates

Yahoo FinanceOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical's Consolidated Net Profit Grows in Fiscal Q1

marketscreener.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

WHO proposes regulatory recommendations to support pharmaceutical decarbonisation

European Pharmaceutical ReviewOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

AI Cognitive Health Startup Mantis Biotech Rethinks How Women Are Diagnosed

ForbesOriginal source

🌍Jul 31Industrytizianalifesciences.comTier 1 · Company source

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

Tiziana Life SciencesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Tenax expects Phase 3 LEVEL trial data in August 2026

Stock TitanOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Radiopharm Theranostics Reports Business Update

GlobeNewswireOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswireOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

‘Hold back names, photos’: Hospitality bodies push back against FDA crackdown

The Indian ExpressOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR

RTTNewsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Wet AMD Drug Secures First FDA-Approved Bevacizumab Status

Streetwise ReportsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

marketscreener.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

China Leapfrogs into Global Biotech

Asia SentinelOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

EU regulatory roundup: AbbVie, Pfizer & BioNTech and Incyte net approvals

Pharmaceutical TechnologyOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Superbug Fighter Recce Pharmaceuticals (ASX:RCE) Steps Into the Global Biodefence Spotlight

KalkineOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Proposed COINS Act Seeks to Restrict U.S. Capital Investment in Chinese Biotech Sector

geneonline.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Italfarmaco Announces Managed Entry Agreement in Georgia

GlobeNewswireOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Boosting CGT access: a global consideration with wide-spanning benefits

Pharmaceutical TechnologyOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

How pharmacists are storing medicines in soaring temperatures

The Pharmaceutical JournalOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

RBF Capital LLC Sells 30,000 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

A New Kind of HIV Pill Just Passed Its First Test in Humans

ScienceAlertOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Sun Pharma's quarterly profit jumps on strength in specialty medicines

reuters.comOriginal source

🇺🇸Jul 31Researchmdanderson.orgTier 2 · Direct publisher

How to manage neuropathy during cancer treatment

MD Anderson Cancer CenterOriginal source